Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

Sara Feola; Salvatore Russo; Beatriz Martins; Alessandra Lopes; Gaëlle Vandermeulen; Vinciane Fluhler; Camilla De Giorgi; Manlio Fusciello; Sari Pesonen; Erkko Ylösmäki; Gabriella Antignani; Jacopo Chiaro; Firas Hamdan; Michaela Feodoroff; Mikaela Grönholm; Vincenzo Cerullo

doi:10.3389/fimmu.2022.826164

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

Sara Feola, Salvatore Russo, Beatriz Martins, Alessandra Lopes, Gaëlle Vandermeulen, Vinciane Fluhler, Camilla De Giorgi, Manlio Fusciello, Sari Pesonen, Erkko Ylösmäki, Gabriella Antignani, Jacopo Chiaro, Firas Hamdan, Michaela Feodoroff, Mikaela Grönholm, Vincenzo Cerullo

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	826164
Lehti	Frontiers in Immunology
Vuosikerta	13
Sivumäärä	16
ISSN	1664-3224
DOI - pysyväislinkit	https://doi.org/10.3389/fimmu.2022.826164
Tila	Julkaistu - 14 huhtik. 2022
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

Funding Information:
This work has been supported by the European Research Council under the European Union’s Horizon 2020 Framework program (H2020)/ERC-CoG-2015 Grant Agreement No. 681219, the Helsinki Institute of Life Science (HiLIFE), the Jane and Aatos Erkko Foundation (decision 19072019), the Cancer Society of Finland (Syöpäjärjestöt).

Funding Information:
We thank all the participants for their support and advice. Moreover, flow cytometry analysis was performed at the HiLife Flow Cytometry Unit, University of Helsinki.

Publisher Copyright:
Copyright © 2022 Feola, Russo, Martins, Lopes, Vandermeulen, Fluhler, De Giorgi, Fusciello, Pesonen, Ylösmäki, Antignani, Chiaro, Hamdan, Feodoroff, Grönholm and Cerullo.

Tieteenalat

3122 Syöpätaudit
317 Farmasia

Pääsy asiakirjaan

10.3389/fimmu.2022.826164

fimmu-13-826164Lopullinen julkaistu versio, 5,26 MBLisenssi: CC BY

Siteeraa tätä

Feola, S., Russo, S., Martins, B., Lopes, A., Vandermeulen, G., Fluhler, V., De Giorgi, C., Fusciello, M., Pesonen, S., Ylösmäki, E., Antignani, G., Chiaro, J., Hamdan, F., Feodoroff, M., Grönholm, M., & Cerullo, V. (2022). Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Frontiers in Immunology, 13, [826164]. https://doi.org/10.3389/fimmu.2022.826164

@article{235cffc623b244f78e8600b271aec57e,

title = "Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine",

keywords = "3122 Cancers, 317 Pharmacy, cancer vaccines, oncolytic viruses, PeptiCRAd, personalized medicine, tumor antigens, IMMUNITY, SENSITIVITY, ADENOVIRUS, ONCOLOGY, IMMUNOTHERAPY, NEOANTIGENS, CTLA-4, BLOCKADE, VIRUSES",

author = "Sara Feola and Salvatore Russo and Beatriz Martins and Alessandra Lopes and Ga{\"e}lle Vandermeulen and Vinciane Fluhler and {De Giorgi}, Camilla and Manlio Fusciello and Sari Pesonen and Erkko Yl{\"o}sm{\"a}ki and Gabriella Antignani and Jacopo Chiaro and Firas Hamdan and Michaela Feodoroff and Mikaela Gr{\"o}nholm and Vincenzo Cerullo",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 Feola, Russo, Martins, Lopes, Vandermeulen, Fluhler, De Giorgi, Fusciello, Pesonen, Yl{\"o}sm{\"a}ki, Antignani, Chiaro, Hamdan, Feodoroff, Gr{\"o}nholm and Cerullo.",

year = "2022",

month = apr,

day = "14",

doi = "10.3389/fimmu.2022.826164",

language = "English",

volume = "13",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media",

}

TY - JOUR

T1 - Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

AU - Feola, Sara

AU - Russo, Salvatore

AU - Martins, Beatriz

AU - Lopes, Alessandra

AU - Vandermeulen, Gaëlle

AU - Fluhler, Vinciane

AU - De Giorgi, Camilla

AU - Fusciello, Manlio

AU - Pesonen, Sari

AU - Ylösmäki, Erkko

AU - Antignani, Gabriella

AU - Chiaro, Jacopo

AU - Hamdan, Firas

AU - Feodoroff, Michaela

AU - Grönholm, Mikaela

AU - Cerullo, Vincenzo

PY - 2022/4/14

Y1 - 2022/4/14

KW - 3122 Cancers

KW - 317 Pharmacy

KW - cancer vaccines

KW - oncolytic viruses

KW - PeptiCRAd

KW - personalized medicine

KW - tumor antigens

KW - IMMUNITY

KW - SENSITIVITY

KW - ADENOVIRUS

KW - ONCOLOGY

KW - IMMUNOTHERAPY

KW - NEOANTIGENS

KW - CTLA-4

KW - BLOCKADE

KW - VIRUSES

U2 - 10.3389/fimmu.2022.826164

DO - 10.3389/fimmu.2022.826164

M3 - Article

AN - SCOPUS:85128914394

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

M1 - 826164

ER -